Dravet Syndrome Market Regional Analysis:
North American Market Insights
Dravet syndrome treatment market in North America industry is predicted to dominate majority revenue share of 39% by 2035 impelled by the rising spending in healthcare. This has led to an increase in research & development of more efficient and effective treatments for Dravet syndrome in the region, which would also improve access to the treatment of the disease in the region. According to estimates, in 2021, the United States spent over 2% more on health care, amounting to roughly USD 4 trillion.
European Market Insights
The Europe dravet syndrome Treatment market is estimated to be the second largest, during the forecast timeframe led by growing development of new drugs. For instance, Europe serves as the world's center for medication development, as over 72 novel opioids have been discovered on the European drug market between 2009 and 2022. This has led to an expansion in treatment options for Dravet syndrome in the region.
